No Consensus on the Advantages and Disadvantages of Its Exclusive Use.

This report focuses on three types of prescription drug labeling approved by the U.S. Food & Drug Administration (FDA). These include the prescribing information intended for health care practitioners, the medication guides intended to inform patients about drugs FDA has determined that pose a serious and significant public health concern, and patient package inserts required for oral contraceptives and estrogens. It discusses the merits and demerits of relying on electronic labeling.